Newbridge Financial Services Group’s Psychemedics Corporation PMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-150
Closed -$885 1525
2022
Q3
$1K Hold
150
﹤0.01% 1359
2022
Q2
$1K Hold
150
﹤0.01% 1322
2022
Q1
$1K Hold
150
﹤0.01% 1410
2021
Q4
$1K Hold
150
﹤0.01% 1379
2021
Q3
$1K Hold
150
﹤0.01% 1342
2021
Q2
$1K Hold
150
﹤0.01% 1405
2021
Q1
$1K Hold
150
﹤0.01% 1345
2020
Q4
$1K Sell
150
-3,500
-96% -$15.2K ﹤0.01% 1084
2020
Q3
$16K Buy
+3,650
New +$17.8K 0.02% 568

Other funds holding PMD

Newbridge Financial Services Group's PMD Position: Q4 2022 in Review

Newbridge Financial Services Group sold out of Psychemedics Corporation (PMD) in Q4 2022, closing a stake of 150 shares — an estimated $885 sold.

Newbridge Financial Services Group first reported a position in PMD in Q3 2020 and held it in 9 quarters. The position peaked at $16K in Q3 2020. 22 funds tracked by Wall St. Rank hold PMD as of Q4 2022.

  • Newbridge Financial Services Group reported no remaining Psychemedics Corporation position as of Q4 2022 after selling out during the quarter.
  • Newbridge Financial Services Group sold 150 Psychemedics Corporation shares in Q4 2022, an estimated $885.
  • Newbridge Financial Services Group first reported a position in Psychemedics Corporation in Q3 2020 and held it in 9 quarters.
  • Newbridge Financial Services Group's Psychemedics Corporation position peaked at $16K in Q3 2020.
  • 22 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q4 2022.

Based on Newbridge Financial Services Group's 13F filing for Q4 2022, filed 17 Jan 2023.